Adams Harkness downgrades Inamed (Nasdaq: IDMC) from 'Buy' to 'Market Perform' after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE